Francesco Viola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Francesco Viola has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Bhiken I. Naik
Department of Anesthesiology & Neurological Surgery, University of Virginia, Charlottesville, VA, USA
2 shared publicationsDanja S. Groves
From the Department of Anesthesiology, University of Virginia, Charlottesville, Virginia
2 shared publicationsDeborah A. Winegar
HemoSonics, LLC, Charlottesville, Virginia, and Durham, North Carolina
2 shared publications- Deborah A. Winegar
HemoSonics, LLC, Durham, North Carolina, USA
2 shared publications Kenichi Tanaka
Department of Anesthesiology, University of Maryland, Baltimore, MD, USA
2 shared publications- Meghan Brennan
Department of Anesthesiology, University of Florida College of Medicine, Gainesville, FL 32608, USA
2 shared publications
Latest Publications
- Open Access
- 1 April 2025
- Published by BMJ in Trauma Surgery & Acute Care Open
- Vol. 10 (2) , e001672
Multicenter evaluation of the Quantra with the QStat Cartridge in adult trauma patients
Background: Trauma-induced coagulopathy (TIC) occurs in a quarter of trauma patients and is associated with death due to uncontrolled bleeding. Current guidelines recommend viscoelastic testing (VET) to assess coagulopathy and guide transfusions. The Quantra with the QStat Cartridge is a point-of-care (POC) VET device that measures changes in clot stiffness (CS) during coagulation and fibrinolysis using ultrasound detection of resonance. This study aimed to evaluate the performance of the QStat Cartridge in trauma patients compared with rotational thromboelastometry (ROTEM) delta and thromboelastography (TEG) 6s VET devices. Methods: A multicenter prospective observational study was conducted in adult patients meeting criteria for a full trauma team response at eight US level 1 trauma centers. Citrated blood samples drawn on arrival at the hospital or after blood transfusions were analyzed in parallel on QStat, ROTEM or TEG. Correlation between QStat and equivalent VET measurements was assessed by linear regression. Concordance was assessed by agreement of results relative to device-specific normal reference ranges. Results: 259 severely injured patients were enrolled, yielding 271 samples for analysis. Moderate to strong correlations between QStat and corresponding ROTEM and TEG measurements were observed (r=0.64–0.88). The concordance between CS results was 84.5% for QStat CS and EXTEM A10 and 83.3% for CS and citrated rapid TEG maximum amplitude. For fibrinogen-related results, concordance was 81.5% for QStat fibrinogen contribution to clot stiffness (FCS) and FIBTEM A10 and 93.8% for FCS and citrated functional fibrinogen maximum amplitude. For fibrinolysis measurements, the overall agreement between QStat clot stability to lysis and EXTEM ML or CK-LY30 was 97.5% and 92.9%, respectively. Conclusion: QStat provides comparable information to the ROTEM delta and TEG 6s in trauma patients and can be useful for diagnosing TIC and guiding treatment. The Quantra’s simplicity of use, ability to deploy at the POC, and rapid availability of results may provide clinicians with a faster, more convenient means to assess and manage TIC. Level of evidence: Diagnostic test, level II. Trial registration number: NCT04312958.
- 1 April 2025
- Published by BMJ in Trauma Surgery & Acute Care Open
- Vol. 10 (2) , e001672
Open AccessMulticenter evaluation of the Quantra with the QStat Cartridge in adult trauma patients
Background: Trauma-induced coagulopathy (TIC) occurs in a quarter of trauma patients and is associated with death due to uncontrolled bleeding. Current guidelines recommend viscoelastic testing (VET) to assess coagulopathy and guide transfusions. The Quantra with the QStat Cartridge is a point-of-care (POC) VET device that measures changes in clot stiffness (CS) during coagulation and fibrinolysis using ultrasound detection of resonance. This study aimed to evaluate the performance of the QStat Cartridge in trauma patients compared with rotational thromboelastometry (ROTEM) delta and thromboelastography (TEG) 6s VET devices. Methods: A multicenter prospective observational study was conducted in adult patients meeting criteria for a full trauma team response at eight US level 1 trauma centers. Citrated blood samples drawn on arrival at the hospital or after blood transfusions were analyzed in parallel on QStat, ROTEM or TEG. Correlation between QStat and equivalent VET measurements was assessed by linear regression. Concordance was assessed by agreement of results relative to device-specific normal reference ranges. Results: 259 severely injured patients were enrolled, yielding 271 samples for analysis. Moderate to strong correlations between QStat and corresponding ROTEM and TEG measurements were observed (r=0.64–0.88). The concordance between CS results was 84.5% for QStat CS and EXTEM A10 and 83.3% for CS and citrated rapid TEG maximum amplitude. For fibrinogen-related results, concordance was 81.5% for QStat fibrinogen contribution to clot stiffness (FCS) and FIBTEM A10 and 93.8% for FCS and citrated functional fibrinogen maximum amplitude. For fibrinolysis measurements, the overall agreement between QStat clot stability to lysis and EXTEM ML or CK-LY30 was 97.5% and 92.9%, respectively. Conclusion: QStat provides comparable information to the ROTEM delta and TEG 6s in trauma patients and can be useful for diagnosing TIC and guiding treatment. The Quantra’s simplicity of use, ability to deploy at the POC, and rapid availability of results may provide clinicians with a faster, more convenient means to assess and manage TIC. Level of evidence: Diagnostic test, level II. Trial registration number: NCT04312958.
- Open Access
- 29 March 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. Publish Ah (11) , 1216-1225
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation
Blood loss and transfusion of blood products are key concerns during liver transplantation. Whole blood viscoelastic testing (VET) devices have been used to monitor hemostatic function and guide transfusion of blood products in this patient population. The Quantra System with the QStat Cartridge is a new point-of-care, closed-system VET device that measures changes in clot stiffness during coagulation and fibrinolysis using ultrasound detection of resonance. The aim of this multicenter prospective observational study was to evaluate the Quantra System against the ROTEM delta device in monitoring coagulation and fibrinolysis in patients undergoing liver transplantation. One-hundred twenty-five (125) adult subjects (>18 y old) were enrolled across 5 medical centers in the United States. Blood samples were collected at a minimum of 3 time points: pre-incision (baseline), during the anhepatic phase, and after the start of reperfusion. Performance was assessed as the correlation of equivalent measurements from the QStat Cartridge and ROTEM delta INTEM, EXTEM, and FIBTEM assays. In addition, a clinical concordance analysis was performed to assess the agreement between the two devices related to detection of fibrinolysis. The correlation between the two VET devices was strong, with r-values ranging between 0.88 and 0.95, and the overall agreement with respect to detecting fibrinolysis was 90.3% (C.I.: 86.9% - 93.2%). The results indicate that the Quantra with the QStat Cartridge provides comparable information as the ROTEM delta in the assessment of hemostatic function during liver transplant. The Quantra’s simplicity of use and availability of rapid results may provide clinicians with a faster, more convenient means to assess coagulation and fibrinolysis status in the operating room and critical care setting.
- 29 March 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. Publish Ah (11) , 1216-1225
Open AccessMulticenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation
Blood loss and transfusion of blood products are key concerns during liver transplantation. Whole blood viscoelastic testing (VET) devices have been used to monitor hemostatic function and guide transfusion of blood products in this patient population. The Quantra System with the QStat Cartridge is a new point-of-care, closed-system VET device that measures changes in clot stiffness during coagulation and fibrinolysis using ultrasound detection of resonance. The aim of this multicenter prospective observational study was to evaluate the Quantra System against the ROTEM delta device in monitoring coagulation and fibrinolysis in patients undergoing liver transplantation. One-hundred twenty-five (125) adult subjects (>18 y old) were enrolled across 5 medical centers in the United States. Blood samples were collected at a minimum of 3 time points: pre-incision (baseline), during the anhepatic phase, and after the start of reperfusion. Performance was assessed as the correlation of equivalent measurements from the QStat Cartridge and ROTEM delta INTEM, EXTEM, and FIBTEM assays. In addition, a clinical concordance analysis was performed to assess the agreement between the two devices related to detection of fibrinolysis. The correlation between the two VET devices was strong, with r-values ranging between 0.88 and 0.95, and the overall agreement with respect to detecting fibrinolysis was 90.3% (C.I.: 86.9% - 93.2%). The results indicate that the Quantra with the QStat Cartridge provides comparable information as the ROTEM delta in the assessment of hemostatic function during liver transplant. The Quantra’s simplicity of use and availability of rapid results may provide clinicians with a faster, more convenient means to assess coagulation and fibrinolysis status in the operating room and critical care setting.
- Open Access
- 1 January 2021
- Published by Elsevier in Thrombosis Research
- Vol. 197, 88-93
Prediction of hypofibrinogenemia and thrombocytopenia at the point of care with the Quantra® QPlus® System
- 1 January 2021
- Published by Elsevier in Thrombosis Research
- Vol. 197, 88-93
Open AccessPrediction of hypofibrinogenemia and thrombocytopenia at the point of care with the Quantra® QPlus® System
- Open Access
- 3 November 2020
- Published by BMJ in Trauma Surgery & Acute Care Open
- Vol. 5 (1) , e000581
Initial clinical experience with the Quantra QStat System in adult trauma patients
Background: Whole blood viscoelastic testing (VET) devices are routinely used in a variety of clinical settings to assess hemostasis. The Quantra QStat System is a cartridge-based point of care VET device that measures changes in clot stiffness during coagulation and fibrinolysis using ultrasound detection of resonance. The objective of this study was to assess the ability of the Quantra QStat System to detect coagulopathies in trauma patients.Methods: A multicenter observational study was conducted on adult subjects at two level 1 trauma centers. For each subject, whole blood samples were drawn upon arrival to the emergency department and again, in some cases, after administration of blood products and/or antifibrinolytics. Samples were analyzed on the Quantra in parallel to ROTEMdelta. The QStat cartridge provides measures of Clot Time (CT), Clot Stiffness (CS), Fibrinogen and Platelet Contributions to clot stiffness (FCS and PCS), and Clot Stability to Lysis (CSL). Data analyses included linear regression of Quantra and ROTEM parameters and an assessment of the concordance of the two devices for the assessment of hyperfibrinolysis.Results: A total of 56 patients were analyzed. 42% of samples had a low QStat CS value suggestive of an hypocoagulable state. The low stiffness values could be attributed to either low PCS, FCS or combination. Additionally, 13% of samples showed evidence of hyperfibrinolysis based on the QStat CSL parameter. Samples analyzed with ROTEM assays showed a lower prevalence of low CS and hyperfibrinolysis based on EXTEM and FIBTEM results. The correlation of CS, FCS and CT versus equivalent ROTEM parameters was strong with r-values of 0.83, 0.79 and 0.79, respectively.Discussion: This first clinical experience with the Quantra in trauma patients showed that the QStat Cartridge was strongly correlated with ROTEM parameters and that it could detect coagulopathies associated with critical bleeding.Level of evidence: Diagnostic test, Level II.
- 3 November 2020
- Published by BMJ in Trauma Surgery & Acute Care Open
- Vol. 5 (1) , e000581
Open AccessInitial clinical experience with the Quantra QStat System in adult trauma patients
Background: Whole blood viscoelastic testing (VET) devices are routinely used in a variety of clinical settings to assess hemostasis. The Quantra QStat System is a cartridge-based point of care VET device that measures changes in clot stiffness during coagulation and fibrinolysis using ultrasound detection of resonance. The objective of this study was to assess the ability of the Quantra QStat System to detect coagulopathies in trauma patients.Methods: A multicenter observational study was conducted on adult subjects at two level 1 trauma centers. For each subject, whole blood samples were drawn upon arrival to the emergency department and again, in some cases, after administration of blood products and/or antifibrinolytics. Samples were analyzed on the Quantra in parallel to ROTEMdelta. The QStat cartridge provides measures of Clot Time (CT), Clot Stiffness (CS), Fibrinogen and Platelet Contributions to clot stiffness (FCS and PCS), and Clot Stability to Lysis (CSL). Data analyses included linear regression of Quantra and ROTEM parameters and an assessment of the concordance of the two devices for the assessment of hyperfibrinolysis.Results: A total of 56 patients were analyzed. 42% of samples had a low QStat CS value suggestive of an hypocoagulable state. The low stiffness values could be attributed to either low PCS, FCS or combination. Additionally, 13% of samples showed evidence of hyperfibrinolysis based on the QStat CSL parameter. Samples analyzed with ROTEM assays showed a lower prevalence of low CS and hyperfibrinolysis based on EXTEM and FIBTEM results. The correlation of CS, FCS and CT versus equivalent ROTEM parameters was strong with r-values of 0.83, 0.79 and 0.79, respectively.Discussion: This first clinical experience with the Quantra in trauma patients showed that the QStat Cartridge was strongly correlated with ROTEM parameters and that it could detect coagulopathies associated with critical bleeding.Level of evidence: Diagnostic test, Level II.
- Open Access
- 1 April 2020
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 130 (4) , 899-909
Multicenter Evaluation of the Quantra QPlus System in Adult Patients Undergoing Major Surgical Procedures
BACKGROUND: The management of perioperative bleeding and the optimization of the available therapies are subjects of significant clinical interest. Clinical guidelines recommend the use of whole blood viscoelastic testing devices to target the utilization of blood products during major surgical procedures. The Quantra QPlus System is a new cartridge-based viscoelastic testing device based on an innovative ultrasound technology. The aim of this study was to evaluate this new system in a surgical population. METHODS: Two hundred seventy-seven adult subjects were enrolled in a multicenter, prospective observational study consisting primarily of patients undergoing cardiac and major orthopedic surgeries. Samples were obtained at multiple time points for testing on the Quantra QPlus System, the rotational thromboelastometry (ROTEM) delta, and standard coagulation tests. Quantra measurements included Clot Time (CT), Heparinase Clot Time (CTH), Clot Time Ratio (CTR), Clot Stiffness (CS), Fibrinogen (FCS), and Platelet (PCS) Contributions to CS. Data analyses included assessment of the concordance of Quantra parameters with a series of clinical composite indexes formed on the basis of standard coagulation tests in 3 domains representing increased, decreased, and normal/subclinical coagulation function. Linear regression and receiver operator characteristic (ROC) analyses of Quantra parameters with corresponding parameters from ROTEM assays were also performed. RESULTS: The accuracy (overall percent agreement or ratio of true positives and true negatives over the entire population) between the Quantra and the composite indexes was between 72% and 98% depending on the specific parameter. Linear regression analysis indicated that the correlation between ROTEM delta and Quantra was very strong with r values ranging between 0.84 and 0.89. Results from ROC analysis demonstrated sensitivities and specificities in the 80%–90% range when QPlus parameters were used to discriminate ROTEM threshold values currently used in goal-directed treatment algorithms. CONCLUSIONS: This study demonstrated that the Quantra QPlus System is strongly correlated with a well-established viscoelastic testing device and its parameters effectively represent the results from multiple standard laboratory assays. The Quantra has been designed to operate at the point of care with the potential to provide rapid and comprehensive results to aid in the management of coagulopathic patients.
- 1 April 2020
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 130 (4) , 899-909
Open AccessMulticenter Evaluation of the Quantra QPlus System in Adult Patients Undergoing Major Surgical Procedures
BACKGROUND: The management of perioperative bleeding and the optimization of the available therapies are subjects of significant clinical interest. Clinical guidelines recommend the use of whole blood viscoelastic testing devices to target the utilization of blood products during major surgical procedures. The Quantra QPlus System is a new cartridge-based viscoelastic testing device based on an innovative ultrasound technology. The aim of this study was to evaluate this new system in a surgical population. METHODS: Two hundred seventy-seven adult subjects were enrolled in a multicenter, prospective observational study consisting primarily of patients undergoing cardiac and major orthopedic surgeries. Samples were obtained at multiple time points for testing on the Quantra QPlus System, the rotational thromboelastometry (ROTEM) delta, and standard coagulation tests. Quantra measurements included Clot Time (CT), Heparinase Clot Time (CTH), Clot Time Ratio (CTR), Clot Stiffness (CS), Fibrinogen (FCS), and Platelet (PCS) Contributions to CS. Data analyses included assessment of the concordance of Quantra parameters with a series of clinical composite indexes formed on the basis of standard coagulation tests in 3 domains representing increased, decreased, and normal/subclinical coagulation function. Linear regression and receiver operator characteristic (ROC) analyses of Quantra parameters with corresponding parameters from ROTEM assays were also performed. RESULTS: The accuracy (overall percent agreement or ratio of true positives and true negatives over the entire population) between the Quantra and the composite indexes was between 72% and 98% depending on the specific parameter. Linear regression analysis indicated that the correlation between ROTEM delta and Quantra was very strong with r values ranging between 0.84 and 0.89. Results from ROC analysis demonstrated sensitivities and specificities in the 80%–90% range when QPlus parameters were used to discriminate ROTEM threshold values currently used in goal-directed treatment algorithms. CONCLUSIONS: This study demonstrated that the Quantra QPlus System is strongly correlated with a well-established viscoelastic testing device and its parameters effectively represent the results from multiple standard laboratory assays. The Quantra has been designed to operate at the point of care with the potential to provide rapid and comprehensive results to aid in the management of coagulopathic patients.
- Open Access
- 1 April 2019
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 33 (4) , 976-984
Comparison of Coagulation Parameters in Arterial and Venous Blood in Cardiac Surgery Measured Using the Quantra System
- 1 April 2019
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 33 (4) , 976-984
Open AccessComparison of Coagulation Parameters in Arterial and Venous Blood in Cardiac Surgery Measured Using the Quantra System
- 1 December 2016
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 123 (6) , 1372-1379
A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings
Been designed for automated, rapid, near-patient monitoring of hemostasis. The Quantra is based on Sonic Estimation of Elasticity via Resonance Sonorheometry, a proprietary technology that uses ultrasound to measure clot time and clot stiffness from changes in viscoelastic properties of whole blood during coagulation. We present results of internal validation and analytical performance testing of the technology and demonstrate the ability to characterize the key functional components of hemostasis....
- 1 December 2016
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 123 (6) , 1372-1379
A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings
Been designed for automated, rapid, near-patient monitoring of hemostasis. The Quantra is based on Sonic Estimation of Elasticity via Resonance Sonorheometry, a proprietary technology that uses ultrasound to measure clot time and clot stiffness from changes in viscoelastic properties of whole blood during coagulation. We present results of internal validation and analytical performance testing of the technology and demonstrate the ability to characterize the key functional components of hemostasis....